PBM WATCH
  • Home
  • The PBM Problem
    • Problems in the Market
    • How PBMs Affect Cost
    • Conflicts of Interest
    • Our Goals
  • Resources
    • CEA February 2018 Report-PBMs
    • PBM Role in the Healthcare Market Place
    • CVS and Aetna Merger
    • PBM Litigation Overview
    • Academic Articles
    • Testimonies and Letters
    • Any Willing Provider Laws >
      • State AWP Statutes
      • Any Willing Provider Cases
    • Industry White Papers
    • Dealing with PBMs
    • Express Scripts-Medco Merger >
      • Stakeholder opposition to Express Scripts Medco
    • DIR Fees >
      • DIR Fee Legislation
      • News on DIR Fees
    • MAC Information Center >
      • Current State MAC Legislation
      • Pending State MAC Legislation 2014
      • State MAC Initiatives
      • MAC Articles and News
    • PBM Legislation
  • Part D Reform
    • Stakeholder Comments
    • Rebates
    • Congressional Letters
  • News Room
  • Take Action
    • Contact a Legislator
    • Consumer Complaints
  • Links
  • Contact Us
    • Tell Us What You Think!
    • About Us
  • CVS and Aetna Merger

          There is a problem with the modern PBM industry.

About the PBM Problem

Problems in the Market

How PBMs Affect Cost

Our Goals
Health plans are experiencing it, pharmacies are experiencing it, and consumers are experiencing it.

Pharmacy Benefit Managers are one of the most problematic, least regulated and least understood aspects of the healthcare delivery system.  Over 80% of pharmaceuticals in the United States are purchased through PBM networks.  PBMs serve as intermediaries between health plans, pharmaceutical manufacturers and pharmacies, and PBMs establish networks for consumers to receive reimbursement for drugs.  Although the primary function of a PBM initially was simply to create networks and process pharmaceutical claims, these entities have exploited the lack of transparency and created conflicts of interest which have significantly distorted competition, reduced choices for consumers and ultimately increased the cost of drugs. 

The major components of the PBM Problem: 

1.  The Market is Broken
2.  PBMs are Driving Up Costs
3.  Substantial Conflicts of Interest
  • Home
  • The PBM Problem
    • Problems in the Market
    • How PBMs Affect Cost
    • Conflicts of Interest
    • Our Goals
  • Resources
    • CEA February 2018 Report-PBMs
    • PBM Role in the Healthcare Market Place
    • CVS and Aetna Merger
    • PBM Litigation Overview
    • Academic Articles
    • Testimonies and Letters
    • Any Willing Provider Laws >
      • State AWP Statutes
      • Any Willing Provider Cases
    • Industry White Papers
    • Dealing with PBMs
    • Express Scripts-Medco Merger >
      • Stakeholder opposition to Express Scripts Medco
    • DIR Fees >
      • DIR Fee Legislation
      • News on DIR Fees
    • MAC Information Center >
      • Current State MAC Legislation
      • Pending State MAC Legislation 2014
      • State MAC Initiatives
      • MAC Articles and News
    • PBM Legislation
  • Part D Reform
    • Stakeholder Comments
    • Rebates
    • Congressional Letters
  • News Room
  • Take Action
    • Contact a Legislator
    • Consumer Complaints
  • Links
  • Contact Us
    • Tell Us What You Think!
    • About Us
  • CVS and Aetna Merger